Implanet S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALIMP.PA research report →
About the company
Implanet S. A. , together with its associated companies, is dedicated to the research, development, manufacturing, and commercialization of spinal and orthopedic medical implants.
- CEO
- Ludovic Lastennet
- IPO
- 2013
- Employees
- 46
- HQ
- Martillac, FR
Price Chart
- Market Cap
- $25.57M
- P/E
- -5.81
- P/S
- 2.05
- P/B
- 72.87
- EV/EBITDA
- -10.19
- Div Yield
- 0.00%
- Gross Margin
- 50.30%
- Op Margin
- -43.71%
- Net Margin
- -35.13%
- ROE
- 912.92%
- ROIC
- -83.21%
- Revenue
- $12.47M · 32.62%
- Net Income
- $-4,382,000 · -0.37%
- EPS
- $-0.03 · 18.45%
- Op Income
- $-3,928,000
- FCF YoY
- 23.52%
- 52W High
- $0.45
- 52W Low
- $0.08
- 50D MA
- $0.19
- 200D MA
- $0.23
- Beta
- 0.62
- Avg Volume
- 86.06K
Get TickerSpark's AI analysis on ALIMP.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALIMP.PA coverage
Recent articles, reports, and earnings notes.
No research on ALIMP.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALIMP.PA report →Similar companies
Peers in the same neighborhood.